论文信息 - Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial - 字舞流文

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

K. O'Byrne | T. Mok | E. Tan | L. Paz-Ares | S. Lu | V. Hirsh | J. Laskin | M. Boyer | D-W. Kim | D. Lee | K. Park | A. Märten | K. Kölbeck | S. Laurie | Y. Shi | L. Zhang | K. Lee | J.C. Yang | D. Kim | J. Fan | N. Dodd | S. Lu